Good afternoon,
Please find attached a press release regarding the appointment of the father of India’s blood plasma industry, Dr. Ranjeet S. Ajmani, to the role of Chief Executive Officer of Aegros Asia.
Aegros is an Australian technology leader in the US$20B global therapeutic plasma market. Its GMP licensed HaemaFrac® lifts process yields to over 85%, reducing cost and carbon emissions while enhancing product safety.
/Public Release.